BALAXI PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 641.4 INR | -1.69% |
|
+0.52% | +48.34% |
| 05-09 | Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer | CI |
| 05-08 | Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director | CI |
Quotes 5-day view
Delayed Quote NSE India S.E.| 18/05/2024 | 21/05/2024 | 22/05/2024 | 23/05/2024 | |
|---|---|---|---|---|
| Last | 654.6 ₹ | 644.65 ₹ | 652.35 ₹ | 641.35 ₹ |
| Volume | 2 700 | 9 649 | 2 694 | 7 948 |
| Change | +0.93% | -1.52% | +1.19% | -1.69% |
| Opening | 653.00 | 669.95 | 659.00 | 669.00 |
| High | 661.75 | 670.00 | 659.00 | 669.00 |
| Low | 616.20 | 641.10 | 641.55 | 624.90 |
Performance
| 1 day | -1.69% | ||
| 1 week | +0.52% | ||
| Current month | +4.88% | ||
| 1 month | +12.08% | ||
| 3 months | +4.86% | ||
| 6 months | +55.29% | ||
| Current year | +48.34% | ||
| 1 year | +0.43% | ||
| 3 years | +4.01% | ||
| 5 years | +506.19% |
Volumes
marketsDaily volume
7 948
Estimated daily volume
7 948
Avg. Volume 20 sessions
8 167
Daily volume ratio
0.97
Avg. Volume 20 sessions INR
5 237 905.45
Avg. Volume 20 sessions USD
62 907.24
Record volume 1
233 941
Record volume 2
195 504
Record volume 3
187 241
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (INR)
6 626 018 068
Capitalization (USD)
79 578 477
Net sales (INR)
2 793 878 000
Net sales (USD)
33 554 475
Number of employees
400
Sales / Employee (INR)
6 984 695
Sales / Employee (USD)
83 886
Free-Float
89.66 %
Free-Float capitalization (INR)
6 458 043 699
Free-Float capitalization (USD)
77 561 105
Average Daily Capital Traded
0.08%
Highs and lows
1 week
616.20
677.90
1 month
563.15679.00
Current year
425.00686.30
1 year
399.95686.30
3 years
303.55747.00
5 years
60.001 080.20
10 years
11.501 080.20
Indicators
Moving average 5 days
653.96
Moving average 20 days
606.45
Moving average 50 days
564.30
Moving average 100 days
530.36
Price spread / (MMA5)
+1.97%
Price spread / (MMA20)
-5.44%
Price spread / (MMA50)
-12.01%
Price spread / (MMA100)
-17.31%
STIM
RSI 9 days
64.03
RSI 14 days
63.65
Sector Comparison - Pharmaceuticals Wholesale
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.69% | +0.52% | +48.34% | +0.43% | 79.58M | ||
| +0.12% | +1.17% | +20.53% | +40.76% | 72.45B | ||
| -0.28% | -1.09% | -4.71% | +11.71% | 23.46B | ||
| -0.23% | -4.88% | +4.89% | -20.26% | 8.59B | ||
| -0.67% | -3.71% | +7.11% | -19.02% | 8.35B | ||
| -3.04% | -5.95% | -23.73% | -26.86% | 7.88B | ||
| +0.54% | -1.79% | +13.92% | -5.52% | 5.21B | ||
| +1.41% | +1.55% | -0.59% | -17.93% | 4.11B | ||
| -2.70% | -8.47% | +7.85% | -1.56% | 4.09B | ||
| -0.06% | -5.40% | +20.65% | -13.44% | 3.6B | ||
| +1.20% | -0.97% | -1.82% | -0.44% | 2.98B | ||
| +0.80% | -6.01% | +29.91% | -16.78% | 2.64B | ||
| -1.94% | -1.31% | -9.59% | +14.76% | 2.4B | ||
| -2.43% | -3.56% | -2.86% | -24.65% | 2.3B | ||
| +0.26% | +0.30% | -1.24% | +22.96% | 2.28B | ||
| +1.02% | -0.29% | +17.01% | +40.57% | 1.46B | ||
| Average | -0.48% | -2.01% | +7.85% | -0.95% | ||
| Weighted average by Cap. | -0.23% | -0.77% | +10.12% | +16.93% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
41b99027d7d239d.btNXBp659U-DmbkuizEwDbHiC74imET02PNfY9VF9d8.WZoNMaj_piiy6otL4V0IbIOPSNhVzxSX6otrNOF1rIgE5QhF8Yu3N-D4iQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 10:59:52 | 641 | 21 | 7,948 |
| 10:59:13 | 642 | 1 | 7,927 |
| 10:59:04 | 640 | 4 | 7,926 |
| 10:57:51 | 642 | 1 | 7,922 |
| 10:57:43 | 642 | 1 | 7,921 |
| 10:57:38 | 642 | 5 | 7,920 |
| 10:57:13 | 640 | 10 | 7,915 |
| 10:56:12 | 642 | 7 | 7,905 |
Monthly variations
Annual change
| 2024 | +48.34% | ||
| 2023 | -28.80% | ||
| 2022 | +18.34% | ||
| 2021 | -21.05% | ||
| 2020 | +700.37% | ||
| 2019 | +184.91% | ||
| 2018 | +91.92% | ||
| 2017 | -22.66% | ||
| 2016 | -25.15% | ||
| 2015 | +87.91% |
- Stock Market
- Equities
- BALAXI Stock
- Quotes Balaxi Pharmaceuticals Limited
